Skin Care News

ORLANDO — Twice-daily deucravacitinib 3 mg and 6 mg significantly improved cutaneous lupus erythematosus activity by week 16, according to a presenter at the American Academy of Dermatology Annual Meeting.

ORLANDO — Increasing diversity in research, from basic and translational to clinical science, is more important than ever and clinicians need to meet people where they are to do so, according to a panel discussion here.

ORLANDO — Ruxolitinib cream 1.5% shows “breakthrough” results as a treatment for prurigo nodularis, according to a presenter at the American Academy of Dermatology Annual Meeting.

ORLANDO — Outgoing American Academy of Dermatology President Seemal R. Desai, MD, FAAD, passed the torch to Susan C. Taylor, MD, FAAD, who said she will continue pushing efforts to unify the organization during “a time of great disruption.”

ORLANDO — Innovations in treating burn and trauma scars in recent years include updated laser technology, giving practitioners options to help in these difficult cases, according to a speaker here.

Patients with chronic prurigo experience high levels of perceived stress, stigmatization and body dysmorphia which are driven by both demographic and disease factors, according to a study.

The National Rosacea Society has opened its applications for research funding as the grant program celebrates its 25th anniversary, according to a press release.

Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo nodularis in the European Union, Galderma announced in a press release.

MIAMI BEACH, Fla. — As the U.S. continues to wait for newer sunscreen ingredients, patients should use tinted sunscreens to protect against visible light that causes photodamage, melasma and hyperpigmentation, according to a speaker here.